Skip to main content

Medications for Multiple Sclerosis - Page 3

The medications listed below are related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
PediaPred Rate Add review
Rx C N
Generic name:
prednisolone systemic
Drug class:
glucocorticoids
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
peginterferon beta-1a 5.3 15 reviews for peginterferon beta-1a to treat Multiple Sclerosis
Rx C N X
Generic name:
peginterferon beta-1a systemic
Brand name:
Plegridy
Drug class:
interferons
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Plegridy 5.4 14 reviews for Plegridy to treat Multiple Sclerosis
Rx C N X
Generic name:
peginterferon beta-1a systemic
Drug class:
interferons
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
ponesimod Rate Add review
Rx N
Generic name:
ponesimod systemic
Brand name:
Ponvory
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Ponvory Rate Add review
Rx N
Generic name:
ponesimod systemic
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
prednisolone Rate Add review
Rx C N
Generic name:
prednisolone systemic
Brand names:
Millipred, Millipred DP, Orapred ODT, PediaPred
Drug class:
glucocorticoids
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
prednisone Rate Add review
Rx C N
Generic name:
prednisone systemic
Drug class:
glucocorticoids
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Rebif 6.9 29 reviews for Rebif to treat Multiple Sclerosis
Rx C N X
Generic name:
interferon beta-1a systemic
Drug class:
interferons
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Rebif Rebidose 8.3 4 reviews for Rebif Rebidose to treat Multiple Sclerosis
Rx C N X
Generic name:
interferon beta-1a systemic
Drug class:
interferons
For consumers:
dosage, interactions, side effects
siponimod 7.3 9 reviews for siponimod to treat Multiple Sclerosis
Rx N
Generic name:
siponimod systemic
Brand name:
Mayzent
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Solu-Medrol 9.0 1 review for Solu-Medrol to treat Multiple Sclerosis
Rx C N
Generic name:
methylprednisolone systemic
Drug class:
glucocorticoids
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Tascenso ODT Rate Add review
Rx C N
Generic name:
fingolimod systemic
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Tecfidera 6.3 98 reviews for Tecfidera to treat Multiple Sclerosis
Rx C N
Generic name:
dimethyl fumarate systemic
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
teriflunomide 5.5 88 reviews for teriflunomide to treat Multiple Sclerosis
Rx X N X
Generic name:
teriflunomide systemic
Brand name:
Aubagio
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Tyruko Rate Add review
Rx C N
Generic name:
natalizumab systemic
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
Tysabri 7.9 97 reviews for Tysabri to treat Multiple Sclerosis
Rx C N
Generic name:
natalizumab systemic
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
ublituximab 9.0 6 reviews for ublituximab to treat Multiple Sclerosis
Rx N
Generic name:
ublituximab systemic
Brand name:
Briumvi
Drug class:
CD20 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
valacyclovir Off-label 9.5 2 reviews for valacyclovir to treat Multiple Sclerosis
Rx B N
Generic name:
valacyclovir systemic
Drug class:
purine nucleosides
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
Vumerity 9.4 6 reviews for Vumerity to treat Multiple Sclerosis
Rx N X
Generic name:
diroximel fumarate systemic
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Zeposia 8.7 4 reviews for Zeposia to treat Multiple Sclerosis
Rx N
Generic name:
ozanimod systemic
Drug class:
selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information

Frequently asked questions

View more FAQ

Topics under Multiple Sclerosis

Learn more about Multiple Sclerosis

Care guides

Symptoms and treatments

Medicine.com guides (external)

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.